US2008076725A1PendingUtilityA1
Clathrate of Azithromycin Hydrate With 1,2-Propyleneglycol, Method For The Manufacture Thereof, And Pharmaceutical Composition containing same
Est. expiryApr 25, 2021(expired)· nominal 20-yr term from priority
A61P 31/04A61K 31/7028A61P 31/00C07D 413/14
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a clathrate of azithromycin hydrate with 1,2-propyleneglycol of formula (I), a method for the manufacture thereof, and a pharmaceutical composition containing same. The inventive compound is much less hygroscopic than azithromycin hydrate or crystals known in the art, therefore, it can be useful for the preparation of a medicine for treating various microbial infections. wherein m ranges from 1 to 2 and n, from 0.30 to 0.45.
Claims
exact text as granted — not AI-modified1 - 7 . (canceled)
8 . A non-aqueous pharmaceutical composition for treating bacterial infection, comprising a clathrate compound of azithromycin hydrate with 1,2-propyleneglycol of formula (I) and a pharmaceutically acceptable carrier:Join the waitlist — get patent alerts
Track US2008076725A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.